Discontinued — last reported Q4 '23
Geographic · Property, plant and equipment
Developed Rest of World — Property, plant and equipment
Pfizer Developed Rest of World — Property, plant and equipment decreased by 1.0% to $290.00M in Q4 2023 compared to the prior quarter.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2016
Last reportedQ4 2023Feb 22, 2024
Rolls up toPP&E (Net)
How to read this metric
An increase suggests capital investment in expanding or upgrading production capacity in developed international regions, while a decrease may indicate asset depreciation, divestitures, or a shift toward outsourcing manufacturing.
Detailed definition
This metric represents the net book value of tangible long-term assets, such as manufacturing facilities, laboratories,...
Peer comparison
Peers in the pharmaceutical industry report similar geographic breakdowns of property, plant, and equipment to demonstrate their global manufacturing footprint and regional operational scale.
Metric ID:
pfe_segment_developed_rest_of_world_property_plant_and_equipmentHistorical Data
3 periods
| Q4 '21 | Q4 '22 | Q4 '23 | |
|---|---|---|---|
| Value | $347.00M | $293.00M | $290.00M |
| QoQ Change | — | -15.6% | -1.0% |
| YoY Change | — | -15.6% | -1.0% |
Range$290.00M – $347.00M
Avg YoY Growth-8.3%
Median YoY Growth-8.3%
Current Streak2+ quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Pfizer's developed rest of world — property, plant and equipment?
- Pfizer (PFE) reported developed rest of world — property, plant and equipment of $290.00M in Q4 2023.
- What does developed rest of world — property, plant and equipment mean?
- The total value of physical assets like factories and equipment owned by the company in developed international markets.